Annual CAPEX
N/A
31 December 2022
Summary:
Eloxx Pharmaceuticals annual capital expenditures is not available.ELOX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
30 September 2023
Summary:
Eloxx Pharmaceuticals quarterly capital expenditures is not available.ELOX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
30 September 2023
Summary:
Eloxx Pharmaceuticals TTM capital expenditures is not available.ELOX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELOX CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ELOX CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
Eloxx Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2015 | $259.60 K(-58.6%) | -$457.80 K(-346.1%) | $259.60 K(-72.3%) |
| Mar 2015 | - | $186.00 K(-5.4%) | $935.50 K(+3.3%) |
| Dec 2014 | - | $196.60 K(-41.3%) | $905.90 K(+10.5%) |
| Sept 2014 | - | $334.80 K(+53.5%) | $819.60 K(+30.6%) |
| June 2014 | $627.70 K(+18.7%) | $218.10 K(+39.5%) | $627.70 K(+15.4%) |
| Mar 2014 | - | $156.40 K(+41.8%) | $543.70 K(+2.8%) |
| Dec 2013 | - | $110.30 K(-22.8%) | $528.70 K(+0.7%) |
| Sept 2013 | - | $142.90 K(+6.6%) | $524.90 K(-0.8%) |
| June 2013 | $529.00 K(+17.4%) | $134.10 K(-5.2%) | $529.00 K(+5.4%) |
| Mar 2013 | - | $141.40 K(+32.8%) | $501.70 K(+6.4%) |
| Dec 2012 | - | $106.50 K(-27.6%) | $471.60 K(+0.6%) |
| Sept 2012 | - | $147.00 K(+37.6%) | $468.70 K(+4.0%) |
| June 2012 | $450.50 K(-34.4%) | $106.80 K(-4.0%) | $450.50 K(-24.1%) |
| Mar 2012 | - | $111.30 K(+7.4%) | $593.20 K(-9.9%) |
| Dec 2011 | - | $103.60 K(-19.6%) | $658.60 K(-3.9%) |
| Sept 2011 | - | $128.80 K(-48.4%) | $685.60 K(-0.1%) |
| June 2011 | $686.40 K(-15.2%) | $249.50 K(+41.2%) | $686.50 K(+23.7%) |
| Mar 2011 | - | $176.70 K(+35.3%) | $555.10 K(-7.6%) |
| Dec 2010 | - | $130.60 K(+0.7%) | $600.90 K(-19.7%) |
| Sept 2010 | - | $129.70 K(+9.8%) | $748.30 K(-7.5%) |
| June 2010 | $809.00 K(+3.2%) | $118.10 K(-46.9%) | $809.00 K(-17.5%) |
| Mar 2010 | - | $222.50 K(-20.0%) | $980.20 K(+9.2%) |
| Dec 2009 | - | $278.00 K(+46.0%) | $897.90 K(+10.1%) |
| Sept 2009 | - | $190.40 K(-34.2%) | $815.80 K(+4.1%) |
| June 2009 | $783.70 K(+2.6%) | $289.30 K(+106.3%) | $783.70 K(+11.4%) |
| Mar 2009 | - | $140.20 K(-28.4%) | $703.70 K(-2.8%) |
| Dec 2008 | - | $195.90 K(+23.8%) | $723.60 K(+2.3%) |
| Sept 2008 | - | $158.30 K(-24.4%) | $707.30 K(-7.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2008 | $763.90 K(+53.4%) | $209.30 K(+30.7%) | $763.90 K(+15.6%) |
| Mar 2008 | - | $160.10 K(-10.9%) | $660.80 K(+8.5%) |
| Dec 2007 | - | $179.60 K(-16.4%) | $609.10 K(+6.7%) |
| Sept 2007 | - | $214.90 K(+102.4%) | $570.90 K(+14.6%) |
| June 2007 | $498.00 K(-37.1%) | $106.20 K(-2.0%) | $498.10 K(-23.5%) |
| Mar 2007 | - | $108.40 K(-23.3%) | $651.50 K(-39.4%) |
| Dec 2006 | - | $141.40 K(-0.5%) | $1.08 M(+15.1%) |
| Sept 2006 | - | $142.10 K(-45.3%) | $934.20 K(+17.9%) |
| June 2006 | $792.10 K(+47.2%) | $259.60 K(-51.2%) | $792.10 K(+16.8%) |
| Mar 2006 | - | $532.50 K(+266.0%) | $678.00 K(+26.0%) |
| June 2005 | $538.00 K(+53.6%) | $145.50 K(-62.8%) | $538.00 K(-27.4%) |
| Mar 2005 | - | $390.80 K(>+9900.0%) | $741.10 K(+111.6%) |
| Dec 2004 | - | $0.00(-100.0%) | $350.30 K(-0.5%) |
| Sept 2004 | - | $1700.00(-99.5%) | $352.00 K(+0.5%) |
| June 2004 | $350.30 K(+948.8%) | $348.60 K(>+9900.0%) | $350.30 K(>+9900.0%) |
| Mar 2004 | - | $0.00(-100.0%) | $1700.00(-94.9%) |
| Dec 2003 | - | $1700.00(>+9900.0%) | $33.10 K(-0.6%) |
| June 2003 | $33.40 K(+32.5%) | $0.00(-100.0%) | $33.30 K(-25.8%) |
| Mar 2003 | - | $31.40 K(+3040.0%) | $44.90 K(+156.6%) |
| Dec 2002 | - | $1000.00(+11.1%) | $17.50 K(-33.0%) |
| Sept 2002 | - | $900.00(-92.2%) | $26.10 K(+3.6%) |
| June 2002 | $25.20 K(-4.5%) | $11.60 K(+190.0%) | $25.20 K(+24.1%) |
| Mar 2002 | - | $4000.00(-58.3%) | $20.30 K(-40.1%) |
| Dec 2001 | - | $9600.00(+43.3%) | $33.90 K(+27.9%) |
| June 2001 | $26.40 K(+92.7%) | $6700.00(-61.9%) | $26.50 K(+33.8%) |
| Mar 2001 | - | $17.60 K(>+9900.0%) | $19.80 K(+800.0%) |
| Dec 2000 | - | $0.00(-100.0%) | $2200.00(0.0%) |
| Sept 2000 | - | $2200.00 | $2200.00 |
| June 2000 | $13.70 K | - | - |
FAQ
- What is the all time high annual CAPEX for Eloxx Pharmaceuticals?
- What is the all time high quarterly CAPEX for Eloxx Pharmaceuticals?
- What is the all time high TTM CAPEX for Eloxx Pharmaceuticals?
What is the all time high annual CAPEX for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high annual capital expenditures is $809.00 K
What is the all time high quarterly CAPEX for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high quarterly capital expenditures is $532.50 K
What is the all time high TTM CAPEX for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high TTM capital expenditures is $1.08 M